These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24402838)

  • 1. The off-label utilization of prothrombin complex concentrate with cryoprecipitate as an alternative to plasma transfusion in bleeding patients with acute right ventricular failure.
    Alam A; Cserti-Gazdewich C; Pendergrast J
    Can J Anaesth; 2014 Mar; 61(3):284-6. PubMed ID: 24402838
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen and prothrombin complex concentrate for the management of massive bleeding.
    Innerhofer P
    Wien Klin Wochenschr; 2010 Dec; 122 Suppl 5():S16-7. PubMed ID: 21598441
    [No Abstract]   [Full Text] [Related]  

  • 3. The cryoprecipitate: that old unknown.
    Blasi A; Beltran J; Pereira A; Puig L
    Rev Esp Anestesiol Reanim; 2015 Apr; 62(4):204-12. PubMed ID: 25561426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
    Yamamoto K
    Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation.
    Colavecchia AC; Cohen DA; Harris JE; Thomas JM; Lindberg S; Leveque C; Salazar E
    Transfusion; 2017 Dec; 57(12):3026-3034. PubMed ID: 28960322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastography-targeted management of severe coagulopathy and off-label use of four-factor prothrombin complex concentrate in an infant with massive bleeding.
    Efune PN; Alex G; Journeycake J; Mehta SD
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):170-173. PubMed ID: 31977329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma.
    Nascimento B; Rizoli S; Rubenfeld G; Fukushima R; Ahmed N; Nathens A; Lin Y; Callum J
    Transfus Med; 2011 Dec; 21(6):394-401. PubMed ID: 21851429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to the bleeding patient.
    Marengo-Rowe AJ
    Int Anesthesiol Clin; 1982; 20(4):137-56. PubMed ID: 6816739
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study.
    Ahmed S; Harrity C; Johnson S; Varadkar S; McMorrow S; Fanning R; Flynn CM; O' Riordan JM; Byrne BM
    Transfus Med; 2012 Oct; 22(5):344-9. PubMed ID: 22994449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin complex concentrate for critical bleeding.
    Patanwala AE; Acquisto NM; Erstad BL
    Ann Pharmacother; 2011 Jul; 45(7-8):990-9. PubMed ID: 21730276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
    Motta M; Del Vecchio A; Radicioni M
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
    Görlinger K; Dirkmann D; Hanke AA; Kamler M; Kottenberg E; Thielmann M; Jakob H; Peters J
    Anesthesiology; 2011 Dec; 115(6):1179-91. PubMed ID: 21970887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria.
    Mozes B; Epstein M; Ben-Bassat I; Modan B; Halkin H
    Transfusion; 1989; 29(6):473-6. PubMed ID: 2501916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia.
    Theodoulou A; Berryman J; Nathwani A; Scully M
    Transfus Apher Sci; 2012 Apr; 46(2):159-62. PubMed ID: 22227402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Whether fibrinogen concentrates are necessary in Russia?].
    Galstian GM; Berkovskiĭ AL; Zhuravlev VV; Polokhov DM; Savchenko VG
    Anesteziol Reanimatol; 2014; (3):49-59. PubMed ID: 25306685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate.
    Robblee JA; Wilkes PR; Dickie SJ; Rubens FD; Bormanis J
    Can J Anaesth; 2012 Mar; 59(3):299-303. PubMed ID: 22161243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From plasma transfusion to individualized, goal-directed coagulation factor administration.
    Spahn DR
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S16-9. PubMed ID: 23910532
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities of therapy of plasmatically caused hemorrhages with coagulation-active blood plasma fractions].
    Richter K; Fünfhausen G
    Dtsch Gesundheitsw; 1967 Mar; 22(11):525-6. PubMed ID: 5595950
    [No Abstract]   [Full Text] [Related]  

  • 20. When do we transfuse cryoprecipitate?
    Anderson MA; Glazebrook B; Cutts B; Stevenson L; Bielby L; Borosak M
    Intern Med J; 2013 Aug; 43(8):896-902. PubMed ID: 23425520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.